Tag: CIRSE 2026
CIRSE 2026: Two-year trial results support sirolimus-eluting balloon for patients with...
Treatment with a sustained-release sirolimus-eluting balloon (SLR) for patients with failing arteriovenous fistulas (AVFs) was associated with higher target-lesion primary patency (TLPP) through to...
CIRSE 2026: STRIKE-PE subanalysis finds durable functional and quality-of-life outcomes for...
A subanalysis of the STRIKE-PE trial has provided evidence that treatment with the 16Fr Lightning Flash (Penumbra) computer-assisted vacuum thrombectomy (CAVT) device is associated...
iVascular announces Phase II results for Amber liquid embolic
New Phase II data from the OPAL study, evaluating iVascular's novel liquid embolic Amber ahead of its market launch, were presented at the Cardiovascular...
iVascular presents one-year iliCo results at CIRSE 2026
iVascular has announced the presentation of the final one-year iliCo study results at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual congress (5–9...
